AAMU
AEGON Asset Management (UK) Portfolio holdings
AUM
$7.81B
1-Year Return
26.02%
This Quarter Return
-15.52%
1 Year Return
+26.02%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$5.31B
AUM Growth
-$1.46B
(-22%)
Cap. Flow
-$258M
Cap. Flow
% of AUM
-4.86%
Top 10 Holdings %
Top 10 Hldgs %
37.36%
Holding
183
New
14
Increased
73
Reduced
74
Closed
11
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$63.7M |
| 2 |
Danaher
DHR
|
$47.6M |
| 3 |
Verizon
VZ
|
$45.2M |
| 4 |
PepsiCo
PEP
|
$43.2M |
| 5 |
Essential Utilities
WTRG
|
$32.7M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
$39.2M |
| 2 |
General Motors
GM
|
$37.6M |
| 3 |
AT&T
T
|
$36.2M |
| 4 |
Clorox
CLX
|
$30.1M |
| 5 |
Avery Dennison
AVY
|
$22M |
Sector Composition
| 1 | Technology | 34.78% |
| 2 | Financials | 12.93% |
| 3 | Healthcare | 12.89% |
| 4 | Industrials | 8.46% |
| 5 | Communication Services | 6.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Carlyle Group
CG
$23B
| $1.59M | 0.03% |
50,208
+4,126
| +9% | +$131K |
|
152
Idexx Laboratories
IDXX
$51.8B
| $1.58M | 0.03% |
4,506
+370
| +9% | +$130K |
|
153
Pultegroup
PHM
$27.7B
| $1.52M | 0.03% |
38,356
+2,541
| +7% | +$101K |
|
154
Waters Corp
WAT
$18.2B
| $1.49M | 0.03% |
4,484
-890
| -17% | -$295K |
|
155
Descartes Systems
DSGX
$9.25B
| $1.4M | 0.03% |
22,565
+1,614
| +8% | +$100K |
|
|
156
Avery Dennison
AVY
$13.1B
| $1.35M | 0.03% |
8,334
-136,122
| -94% | -$22M |
|
157
HDFC Bank
HDB
$180B
| $1.27M | 0.02% |
23,056
| – | – |
|
158
Manulife Financial
MFC
$51.9B
| $1.12M | 0.02% |
64,759
| – | – |
|
159
Cemex
CX
$13.6B
| $991K | 0.02% |
253,480
+12,309
| +5% | +$48.1K |
|
160
Roblox
RBLX
$89.8B
| $761K | 0.01% |
23,108
+2,977
| +15% | +$98K |
|
161
Equinix
EQIX
$75.7B
| $608K | 0.01% |
925
+100
| +12% | +$65.7K |
|
162
Jackson Financial
JXN
$6.61B
| $538K | 0.01% |
20,132
| – | – |
|
|
163
Clorox
CLX
$15.4B
| $126K | ﹤0.01% |
897
-214,559
| -100% | -$30.1M |
|
164
Nasdaq
NDAQ
$53.4B
| $6K | ﹤0.01% |
+123
| New | +$6K |
|
165
Viatris
VTRS
$12.2B
| $6K | ﹤0.01% |
531
| – | – |
|
166
Ecolab
ECL
$77.6B
| $5K | ﹤0.01% |
+33
| New | +$5K |
|
167
Edwards Lifesciences
EW
$47.4B
| $4K | ﹤0.01% |
+39
| New | +$4K |
|
168
Trex
TREX
$6.93B
| $3K | ﹤0.01% |
+46
| New | +$3K |
|
169
Verisk Analytics
VRSK
$37.6B
| $3K | ﹤0.01% |
+18
| New | +$3K |
|
170
Alnylam Pharmaceuticals
ALNY
$59.4B
| $2K | ﹤0.01% |
+12
| New | +$2K |
|
171
Cognex
CGNX
$7.51B
| $2K | ﹤0.01% |
+46
| New | +$2K |
|
172
Novo Nordisk
NVO
$244B
| $2K | ﹤0.01% |
+36
| New | +$2K |
|
173
American Water Works
AWK
$27.9B
| – | – |
-46,961
| Closed | -$7.77M |
|
174
GDS Holdings
GDS
$6.32B
| – | – |
-128,900
| Closed | -$5.05M |
|
|
175
General Motors
GM
$55.2B
| – | – |
-858,936
| Closed | -$37.6M |
|